Barinthus Biotherapeutics
Biotechnology company in Oxford, England / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Vaccitech?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Barinthus Biotherapeutics plc (formerly Vaccitech plc) is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer.[1][2] Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Nasdaq: BRNS | |
Industry | |
Founded | 2016; 8 years ago (2016) |
Founder | |
Headquarters | , United Kingdom |
Website | barinthusbio |
Close